GlassScriptPhysician profile
Brenta Medley
NPI 1639162688
$4,046.11
in general payments reported to CMS, 2019-2025
17 companies · $468 in 2025
The $468 reported for 2025 was more than what 75% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,019 · 2020: $258 · 2021: $272 · 2022: $776 · 2023: $783 · 2024: $471 · 2025: $468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,722.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,721.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,432.87 | 2019-2025 | Clariti Contact Lens, Myday Contact Lens, Misight Contact Lens |
| Sun Pharmaceutical Industries INC. | $482.97 | 2019-2025 | Cequa |
| Novartis Pharmaceuticals Corporation | $290.50 | 2019-2023 | |
| Alcon Vision LLC | $259.91 | 2023-2025 | Total30, Clareon, Precision7 |
| Oyster Point Pharma, INC. | $231.09 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Allergan, INC. | $228.62 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $215.61 | 2023-2025 | Infuse, Xiidra, Miebo |
| Abbvie INC. | $198.43 | 2022-2023 | |
| Johnson & Johnson Vision Care, INC. | $148.20 | 2019-2023 | Acuvue |
| Sight Sciences, INC. | $129.56 | 2022 | |
| Glaukos Corporation | $120.27 | 2023 | |
| Kala Pharmaceuticals, INC. | $98.56 | 2020-2022 | |
| Harrow Eye, LLC | $80.12 | 2024 | Vevye |
| Eyevance Pharmaceuticals LLC | $43.17 | 2020-2022 | |
| Mallinckrodt Hospital Products INC. | $39.16 | 2020-2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $30.80 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $16.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brenta Medley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.